For decades, anesthetics have been studied as possible treatments for depression—but what’s the science behind why they could prove to be an effective tool in psychiatry?
Quillivant ER (methylphenidate HCl extended-release) chewable tablets are now available for treatment of attention deficit hyperactivity disorder in children ages six to 12.
Close to 60% of patients in U.S. national ambulatory survey were prescribed two or more psychotropic medications in 2005, a sharp rise from the 42.6% seen in 1996.
Q&A: Two Canadian ADHD experts talk about why there is a surge of patients seeking assessment, the importance of a formal diagnosis, and what physicians need to know to recognize and treat the disorder